BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36096830)

  • 1. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer.
    Li C; Yoshimura T; Tian M; Wang Y; Kondo T; Yamamoto KI; Fujisawa M; Ohara T; Sakaguchi M; Matsukawa A
    Breast Cancer Res; 2022 Sep; 24(1):60. PubMed ID: 36096830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.
    Han B; Zhang H; Tian R; Liu H; Wang Z; Wang Z; Tian J; Cui Y; Ren S; Zuo X; Tian R; Niu R; Zhang F
    Theranostics; 2022; 12(9):4127-4146. PubMed ID: 35673569
    [No Abstract]   [Full Text] [Related]  

  • 3. Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators.
    Wang Y; Ohara T; Chen Y; Hamada Y; Li C; Fujisawa M; Yoshimura T; Matsukawa A
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
    Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
    Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells.
    Takiguchi T; Takahashi-Yanaga F; Ishikane S; Tetsuo F; Hosoda H; Arioka M; Kitazono T; Sasaguri T
    Eur J Pharmacol; 2021 Oct; 909():174415. PubMed ID: 34375673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF13 promotes metastasis of triple-negative breast cancer.
    Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
    Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins.
    Lu H; Wu Z; Wang Y; Zhao D; Zhang B; Hong M
    Phytomedicine; 2022 Sep; 104():154291. PubMed ID: 35839735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR5: A prognostic and monitoring indicator for triple-negative breast cancer.
    Shi D; Zhao S; Jiang W; Zhang C; Liang T; Hou G
    Cell Death Dis; 2019 Dec; 10(12):954. PubMed ID: 31852883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iPSC-Derived Hereditary Breast Cancer Model Reveals the
    Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
    Smith YE; Toomey S; Napoletano S; Kirwan G; Schadow C; Chubb AJ; Mikkelsen JH; Oxvig C; Harmey JH
    BMC Cancer; 2018 Oct; 18(1):1016. PubMed ID: 30348128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
    Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
    J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal GPT2 derived from triple-negative breast cancer cells promotes metastasis by activating BTRC.
    Cui M; Peng J; Zhou Y; Wang X; Cui D
    Thorac Cancer; 2023 Jul; 14(21):2018-2025. PubMed ID: 37287397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity.
    Mu J; Abe Y; Tsutsui T; Yamamoto N; Tai XG; Niwa O; Tsujimura T; Sato B; Terano H; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1996 Sep; 87(9):963-71. PubMed ID: 8878460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis.
    Kusuma N; Denoyer D; Eble JA; Redvers RP; Parker BS; Pelzer R; Anderson RL; Pouliot N
    Int J Cancer; 2012 Feb; 130(3):555-66. PubMed ID: 21387294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSK1 promotes murine breast cancer growth and metastasis.
    Czaplinska D; Gorska M; Mieczkowski K; Peszynska-Sularz G; Zaczek AJ; Romanska HM; Sadej R
    Folia Histochem Cytobiol; 2018; 56(1):11-20. PubMed ID: 29498411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors.
    Ohga N; Ishikawa S; Maishi N; Akiyama K; Hida Y; Kawamoto T; Sadamoto Y; Osawa T; Yamamoto K; Kondoh M; Ohmura H; Shinohara N; Nonomura K; Shindoh M; Hida K
    Am J Pathol; 2012 Mar; 180(3):1294-1307. PubMed ID: 22245217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.
    Chen T; Liu Y; Li C; Xu C; Ding C; Chen J; Zhao J
    Cancer Treat Res Commun; 2021; 28():100412. PubMed ID: 34119765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Deficiency of PTEN Accelerates Breast Cancer Growth and Metastasis.
    Chen J; Sun J; Wang Q; Du Y; Cheng J; Yi J; Xie B; Jin S; Chen G; Wang L; Wang X; Wei H
    Front Oncol; 2022; 12():825484. PubMed ID: 35372075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cells promote triple-negative breast cancer cell metastasis
    Zhang W; Xu J; Fang H; Tang L; Chen W; Sun Q; Zhang Q; Yang F; Sun Z; Cao L; Wang Y; Guan X
    FASEB J; 2018 Jan; 32(1):276-288. PubMed ID: 28899878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.